<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3-mathml3.dtd">
<article xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" dtd-version="1.3" article-type="correction">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Microbiol.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Microbiol.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">1664-302X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fmicb.2025.1730944</article-id>
<article-version article-version-type="Version of Record" vocab="NISO-RP-8-2008"/>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Correction</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Correction: A bibliometric analysis and systematic review of drug repurposing against drug-resistant ESKAPE pathogens: a particular focus on <italic>Pseudomonas aeruginosa</italic></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<collab>Frontiers Production Office</collab>
<xref ref-type="aff" rid="aff1"/>
<xref ref-type="corresp" rid="c001"><sup>&#x0002A;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/20170"/>
</contrib>
</contrib-group>
<aff id="aff1"><institution>Frontiers Media SA</institution>, <city>Lausanne</city>, <country country="ch">Switzerland</country></aff>
<author-notes>
<corresp id="c001"><label>&#x0002A;</label>Correspondence: Frontiers Production Office, <email xlink:href="mailto:production.office@frontiersin.org">production.office@frontiersin.org</email></corresp>
</author-notes>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2025-11-14">
<day>14</day>
<month>11</month>
<year>2025</year>
</pub-date>
<pub-date publication-format="electronic" date-type="collection">
<year>2025</year>
</pub-date>
<volume>16</volume>
<elocation-id>1730944</elocation-id>
<history>
<date date-type="received">
<day>23</day>
<month>10</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>23</day>
<month>10</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2025 Frontiers Production Office.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Frontiers Production Office</copyright-holder>
<license>
<ali:license_ref start_date="2025-11-14">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<related-article id="RA1" related-article-type="corrected-article" journal-id="Front. Microbiol." journal-id-type="nlm-ta" vol="16" page="1669585" xlink:href="10.3389/fmicb.2025.1669585" ext-link-type="doi">A Correction on <article-title>A bibliometric analysis and systematic review of drug repurposing against drug-resistant ESKAPE pathogens: a particular focus on <italic>Pseudomonas aeruginosa</italic></article-title> by Guo, S., Li, L., Zhang, Q., Liu, H., Yao, X., Liang, L., and Chen, C. (2025). <italic>Front. Microbiol</italic>. 16:1669585. doi: <object-id>10.3389/fmicb.2025.1669585</object-id></related-article>
<kwd-group>
<kwd>drug repurposing</kwd>
<kwd>drug-resistant ESKAPE</kwd>
<kwd>drug-resistant <italic>Pseudomonas aeruginosa</italic></kwd>
<kwd>bibliometric analysis</kwd>
<kwd>systematic review</kwd>
</kwd-group>
<funding-group>
<funding-statement>The author(s) declare that no financial support was received for the research or publication of this article.</funding-statement>
</funding-group>
<counts>
<fig-count count="0"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="0"/>
<page-count count="1"/>
<word-count count="292"/>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Antimicrobials, Resistance and Chemotherapy</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<p>Incorrect Funding and Acknowledgement statements were published.</p>
<p>The correct statements are below:</p>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>Macao Polytechnic University (Grant No. RP/FCA-12/2023) and Macao Science and Technology Development Fund (Grant No. 0021/2024/ITP1).</p>
<p>The original version of this article has been updated.</p>
</ack>
<fn-group>
<fn fn-type="custom" custom-type="edited-by" id="fn0001">
<p>Approved by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/228891/overview">Frontiers Editorial Office</ext-link>, Frontiers Media SA, Switzerland</p>
</fn>
</fn-group>
</back>
</article>